Nemus Bioscience (NMUS) 3.4000 $NMUS NEMUS Bioscience: A

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nemus Bioscience (NMUS) 3.4000 $NMUS

NEMUS Bioscience: A Unique Approach To The 32 Million Rx U.S. Glaucoma Market
Dallas Salazar - at Seeking Alpha - Fri May 15, 11:42AM CDT


NEMUS Bioscience, Inc. to Attend Upcoming Investment Conferences
Marketwired - Fri May 15, 7:00AM CDT
NEMUS Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids for the treatment of glaucoma, announces that it has been invited to, and will attend, three investor conferences where they will present and conduct one-on-one meetings with investors in May and June.

Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part VII
Anthony Cataldo - at Seeking Alpha - Sun Apr 19, 11:06PM CDT


NEMUS Bioscience, Inc. to Present on Cannabis Investor Webcast
ACCESSWIRE - Wed Apr 08, 6:16PM CDT
COSTA MESA, CA / ACCESSWIRE / April 8, 2015 / NEMUS Bioscience Inc. (NMUS), a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids, will be presenting on the Cannabis Investor Webcast on Thursday, April 9, 2015 at 5:00 PM ET.

NEMUS Bioscience, Inc. Retains MZ Group as Investor Relations Advisor
GlobeNewswire - Tue Mar 24, 6:09AM CDT
NEMUS Bioscience Inc. (OTCQB: NMUS), a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids, announced today it has retained MZ Group as its investor relations advisor.

NEMUS Bioscience, Inc. initiates anti-infective program with focus on MRSA
GlobeNewswire - Wed Mar 18, 6:06AM CDT
NEMUS Bioscience, Inc. (OTCQB: NMUS) announced today that the company would begin studies concerning the medical utility of cannabinoids as anti-infective therapeutics. The initial studies will be performed at the University of Mississippi (UM), a NEMUS strategic collaborative partner and a global leader in the chemistry and science of cannabinoids and botanicals.

Cannabis - The Good, The Bad And The Ugly
Nick Cox - at Seeking Alpha - Mon Mar 09, 4:02AM CDT

INSY: 59.00 (+0.17), GWPH: 112.25 (-0.07)

48 Marijuana Stocks - A Post-Mortem: Part I
Anthony Cataldo - at Seeking Alpha - Tue Mar 03, 1:27AM CST

GWPH: 112.25 (-0.07)

Nemus Unlocks Cannabinoid Potential with Unique Compound
ACCESSWIRE - Tue Feb 17, 8:33AM CST
WHITEFISH, MT / ACCESSWIRE / February 17, 2015 / The market for legalized marijuana grew 74% from $1.5 billion in 2013 to $2.7 billion in 2014, according to ArcView Market Research, with medical marijuana accounting for over 80% of the market. These growth rates are being driven by favorable legislation across the country and growing public support for the legalization of both adult-use and medical marijuana, although there's still strong opposition by a lot of conservatives in the government.
GWPH: 112.25 (-0.07), AMGN: 162.36 (+0.38), GSK: 44.77 (-0.22)

StockNewsNow.com Publishes New SNNLive Video Interview with NEMUS Bioscience, Inc.
ACCESSWIRE - Wed Feb 11, 7:31AM CST
LOS ANGELES, CA / ACCESSWIRE / February 11, 2015 / StockNewsNow.com, the Official MicroCap News Source, today published an SNNLive Video Interview with John Hollister, CEO of NEMUS Bioscience, Inc. (OTCBB: NMUS), a biopharmaceutical company focused on the discovery, development, and the commercialization of cannabis-based therapeutics through partnership with the University of Mississippi for the treatment of a variety of diseases or symptoms suffered by many around the globe. The video interview was recorded in San Francisco, CA at the Healthcare Media Day.

12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part V
Anthony Cataldo - at Seeking Alpha - Tue Jan 13, 1:03PM CST

GWPH: 112.25 (-0.07)

NEMUS Bioscience Announces Appointment of Thomas A. George, CFO of Deckers Brands, to Its Board of Directors
GlobeNewswire - Mon Jan 12, 7:00AM CST
NEMUS Bioscience, Inc. (OTCQB:NMUS) announced the appointment of Thomas (Tom) A. George, current Chief Financial Officer of Deckers Brands (NYSEECK), to its Board of Directors. Mr. George will also be responsible for chairing the Company's audit committee. Mr. George has over thirty years of experience in corporate finance and accounting, having served in a number of senior level positions with both public and private companies. Mr. George joined Deckers Brands as Chief Financial Officer in September 2009. Prior to Deckers, Mr. George was with Ophthonix, Inc. where he served as Chief Financial Officer since February 2005. Prior to Ophthonix, Mr. George spent more than seven years as Chief Financial Officer for publicly held Oakley, Inc., now a division of Luxottica Group S.p.A. Earlier in his career, Mr. George held positions at Loral Corporation, International Totalizator Systems, Remec Corporation and Coopers and Lybrand. Mr. George is a graduate of the University of Southern California.
DECK: 72.27 (-0.15)

12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part III
Anthony Cataldo - at Seeking Alpha - Fri Jan 09, 12:29PM CST

GWPH: 112.25 (-0.07)

NEMUS to Move Forward With Cannabinoid-Based Therapy for Open-Angle Glaucoma
GlobeNewswire - Thu Dec 04, 12:05PM CST
NEMUS Bioscience, Inc. (OTC:NMUS) reports that data recently presented at the American Association of Pharmaceutical Scientists (AAPS) meeting in San Diego by Dr. Soumyajit Majumdar, Associate Professor of Pharmaceutics, University of Mississippi, showed that a pro-drug formulation of Δ-tetrahydrocannabinol (THC), in-licensed from the University of Mississippi, achieved company goals of significantly lowering intra-ocular pressure (IOP) in an open-angle rabbit glaucoma model.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Century's Florence Model Openings Put Arizona in Focus

Updated Category News Views 18

Six furnished houses in Florence may sound like a modest ribbon-cutting, but homebuilding is a business of small field signals before the quarterly numbers ever show up. Century Communities is scheduled to host a November grand opening for six model homes spanning two new communities in Florence, Arizona. For investors tracking NYSE:CCS, that is not a thesis by itself. It...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 15

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
Four Pending Deals Put Shareholder Terms Under Scrutiny

Updated Category News Views 88

Four corporate transactions landed under a legal microscope on November 18, and that is never background noise for shareholders trying to judge whether the paperwork matches the price. Halper Sadeh LLC says it is investigating proposed deals involving WaFd, Personalis, Dana and Baldwin Group for possible federal securities-law violations and/or fiduciary-duty breaches....

Continue Reading
The Estate Bets Over $1 Billion on Luxury Longevity

Updated Category News Views 0

A billion-dollar wellness promise just wandered into the condominium market. The Estate by sbe says its first three branded residential developments carry combined real estate value above $1 billion and encompass more than 500 units. That is not pocket change, and it is certainly not a routine hotel-brand licensing exercise dressed up with scented candles and a cold...

Continue Reading
Hitachi's Quiet Fusion Bet Is Really About Data Control

Updated Category News Views 16

Weeks of engineering work can vanish because one storage system hiccups, which is a rotten way to learn that data infrastructure belongs in the mission-critical column. Esteyco’s new environment, built with Hitachi Vantara and implemented by Quadrics Sistemas, is not a fusion breakthrough. It is the less glamorous machinery that keeps serious fusion research from...

Continue Reading
GE Aerospace Backs Service Members With $100K Gift

Updated Category News Views 0

A six-figure commitment can look tiny beside jet-engine budgets, yet it can matter a great deal when it reaches people navigating the awkward jump from military service into civilian life. GE Aerospace has committed $100,000 to Embry-Riddle Aeronautical University to support transitioning service members. That is the whole heart of this announcement, and frankly, it is...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 87

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
Ivanti's AI Push Rests on Data, Control and Results

Updated Category News Views 107

Enterprise AI has a nasty habit of sounding brilliant right up until it meets a messy fleet of laptops, phones, patches and permissions. Ivanti’s latest product push is aimed squarely at that unglamorous collision point: giving AI systems governed access to the operational data inside Ivanti Neurons, then keeping humans and pre-set permissions in charge of what happens...

Continue Reading
Rokt's 164% Growth Shows Checkout Ads Have Real Muscle

Updated Category News Views 0

Checkout screens have become valuable real estate, and Rokt is planting a flag right in the middle of them. The New York ecommerce technology company landed on Deloitte's 2026 Technology Fast 500 after posting 164% revenue growth from 2022 through 2025. That is a meaningful number, not decorative corporate confetti, especially in a digital-ad market where plenty of...

Continue Reading
Villa Group’s Punta Mita Bet Adds 305 Luxury Resort Keys

Updated Category News Views 102

A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...

Continue Reading

Top 5 Most Recently Viewed Articles

Apple Inc. Faces Class Action Lawsuit Over Securities Fraud

Updated Category News Views 299

Overview of the Class Action Lawsuit Against Apple Inc. The renowned law firm of Kessler Topaz Meltzer & Check, LLP has announced a significant class action lawsuit filed against Apple Inc. The lawsuit, now underway in the United States District Court for the Northern District of California, is focused on claims of securities fraud that impact investors of Apple...

Continue Reading
Oslo Stock Market Experiences Decline Amidst Mixed Performances

Updated Category News Views 102

Oslo Stock Market Experiences Decline The recent trading session on the Oslo Stock Exchange closed with a notable decline, reflecting a complex mixture of performances across various sectors. Generally, the market is affected by fluctuations in key industries such as Media, Transport, and Diversified Financials. Sector Performance Analysis The Oslo OBX index, a critical...

Continue Reading
Doodle's Tender Offer Results: Lexibook Holds Strong Position

Updated Category News Views 210

Doodle's Tender Offer Results Overview In a strategic move within the shares market, the results from Doodle's recent tender offer on Lexibook have been announced. This development is particularly interesting for investors and stakeholders in the electronic leisure products sector. The outcome signifies a notable consolidation of shares following the initiation of...

Continue Reading
Riot Platforms Sees Bullish Signals as Options Trade Surge

Updated Category News Views 283

Riot Platforms Sees Bullish Signals in Options Trading Recent market activities suggest that investors with significant capital are betting on a positive future for Riot Platforms (NASDAQ: RIOT). This turn towards bullish behavior in the stock market highlights the enthusiasm among wealthier traders and institutional investors. The fascinating aspect of this situation is...

Continue Reading
Highlights from Coloplast A/S Annual Meeting and Future Outlook

Updated Category News Views 215

Coloplast A/S Annual General Meeting Insights Coloplast A/S recently hosted its Annual General Meeting, where significant resolutions were discussed and approved. As the company continues to innovate in healthcare, these decisions reflect their commitment to improving the lives of millions. Annual Report Approval One of the main highlights at the meeting was the approval...

Continue Reading